BioXcel’s Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use.
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
Where Today's News Shapes Tomorrow
